Drugs / AGS-16M18
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00816686 | Oct 2008 → Apr 2010 | renal cell carcinoma | Astellas Pharma Inc | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGS-16M18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00816686 ↗ |
| Route | Intravenous | “IV Infusion” NCT00816686 ↗ |